Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

2.2K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
2.2K
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

49
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
49
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

3.2K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
3.2K
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

3.6K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.6K
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

1.7K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
1.7K
Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

25
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
25

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A novel <i>TBK1</i> mutation in a family with diverse frontotemporal dementia spectrum disorders.

Cold Spring Harbor molecular case studies·2019
Same author

Contractures and muscle disease.

Practical neurology·2016
Same author

South Wales joint neuroscience meeting, Bridgend, 29 April 2010: a 66-year-old man who suddenly couldn't drive.

Practical neurology·2011
See all related articles

Related Experiment Video

Updated: Apr 28, 2026

Immunolabelling Myofiber Degeneration in Muscle Biopsies
06:37

Immunolabelling Myofiber Degeneration in Muscle Biopsies

Published on: December 5, 2019

8.5K

Muscle diseases: mimics and chameleons.

R Jon Walters

    Practical Neurology
    |June 15, 2014
    PubMed
    Summary

    Neurologists encounter muscle diseases, though less common than headaches. A methodical diagnostic approach is crucial to avoid misdiagnosing similar-presenting conditions and ensure accurate identification.

    Area of Science:

    • Neurology
    • Clinical Medicine

    Background:

    • Muscle diseases are encountered in general neurology clinics.
    • While less common than headaches, their diagnosis requires careful consideration.

    Observation:

    • Diagnostic processes can be complex and challenging.
    • Similar-presenting conditions can complicate accurate diagnosis.

    Findings:

    • A methodical approach is essential for neurological problem-solving.
    • Ensuring all diagnostic criteria align ('ducks all line up') prevents diagnostic errors.

    Implications:

    • Accurate diagnosis of muscle diseases is critical for effective patient management.
    • Avoiding mistaken identity in neurological diagnoses improves patient outcomes.
    Keywords:
    MUSCLE DISEASE

    More Related Videos

    Behavioral and Locomotor Measurements Using an Open Field Activity Monitoring System for Skeletal Muscle Diseases
    06:52

    Behavioral and Locomotor Measurements Using an Open Field Activity Monitoring System for Skeletal Muscle Diseases

    Published on: September 29, 2014

    56.9K
    Engineering and Characterization of an Optogenetic Model of the Human Neuromuscular Junction
    11:07

    Engineering and Characterization of an Optogenetic Model of the Human Neuromuscular Junction

    Published on: April 14, 2022

    2.1K

    Related Experiment Videos

    Last Updated: Apr 28, 2026

    Immunolabelling Myofiber Degeneration in Muscle Biopsies
    06:37

    Immunolabelling Myofiber Degeneration in Muscle Biopsies

    Published on: December 5, 2019

    8.5K
    Behavioral and Locomotor Measurements Using an Open Field Activity Monitoring System for Skeletal Muscle Diseases
    06:52

    Behavioral and Locomotor Measurements Using an Open Field Activity Monitoring System for Skeletal Muscle Diseases

    Published on: September 29, 2014

    56.9K
    Engineering and Characterization of an Optogenetic Model of the Human Neuromuscular Junction
    11:07

    Engineering and Characterization of an Optogenetic Model of the Human Neuromuscular Junction

    Published on: April 14, 2022

    2.1K